Xcout IntelSign inSubscribe

Divi's Laboratories competitors & alternatives

DIVISLABPharmaceuticalsIndia

The 12 closest competitors and alternatives to Divi's Laboratories among pharmaceuticals companies — ranked by similarity to what Divi's Laboratories actually does, not by market-cap band.

12Competitors listed

Subscribe to see Divi's Laboratories’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Divi's Laboratories

Divi's Laboratories manufactures generic Active Pharmaceutical Ingredients (APIs), intermediates, and nutraceutical ingredients, while also providing custom synthesis services for pharmaceutical companies. The company serves global pharmaceutical, nutritional, food, and beverage industries by supplying small molecules, peptides, carotenoids, and vitamins.

Divi's Laboratories at a glance

Divi's Laboratories is a pharmaceuticals company headquartered in India. Xcout tracks 10 named people at Divi's Laboratories, including Dr. Kiran S. Divi (Whole-Time Director & Chief Executive Officer).

Divi's Laboratories leadership

  • Dr. Kiran S. DiviWhole-Time Director & Chief Executive Officer
  • Dr. Ramesh B.V. NimmagaddaNon-Executive Chairman & Independent Director
  • Dr. Murali K. DiviManaging Director
  • Dr. Rajendra Kumar PremchandIndependent Director
  • Dr. S. Devendra RaoWhole-time Director (Manufacturing)
  • Mr. K.V. ChowdaryIndependent Director

4 more named people on record for Divi's Laboratories, with roles, board committees and tenure — see the full roster →

Top 12 Divi's Laboratories competitors

Ranked by semantic similarity — how close each company is to Divi's Laboratories by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

Dr. Reddy's LaboratoriesRDY · PharmaceuticalsHyderabad, India
72% matchPublicAI 18/100 ▲Green 28/100 ▼

Similar pharmaceuticals company

Dr. Reddy's Laboratories Limited, alongside its associated companies, functions as a holistic pharmaceutical entity with a global footprint. Its business operations are divided into several key divisions. The Global Generics segment is responsible for the manufacturing and sale of both prescription and over-the-counter finished pharmaceutical products. These offerings are available either under a proprietary brand or as generic formulations that are therapeutically identical to their branded equivalents. This segment also includes the company's biologics ventures. The Pharmaceutical Services and Active Ingredients (PSAI) division focuses on producing and distributing active pharmaceutical ingredients (APIs) and chemical intermediates, which serve as crucial building blocks for final drug products. Additionally, PSAI provides contract research services and produces custom-specified APIs and steroids for clients. The Proprietary Products segment is dedicated to the research and advancement of unique pharmaceutical formulations. The Others segment is actively involved in developing treatments, primarily for oncology (cancer) and inflammatory conditions. Dr. Reddy's addresses a broad spectrum of therapeutic areas, including gastrointestinal issues, cardiovascular health, diabetes, dermatological concerns, cancer, respiratory diseases, oral health, urological disorders, and nephrological conditions. The company has also established a partnership with Curis, Inc., centered on the discovery, development, and commercialization of small molecule antagonists designed for immuno-oncology and precision oncology targets. Founded in 1984, Dr. Reddy's Laboratories Limited maintains its principal office in Hyderabad, India.

Market cap$10.4B
Employees27,527
GCPSparkPythonAzureAirflow
Dr. Reddy's Laboratories competitors & alternatives →
Solara Active Pharma Sciences LimitedSOLARA · PharmaceuticalsChennai, India
70% matchPublic

Similar pharmaceuticals company

Solara Active Pharma Sciences Limited is an Indian-based pharmaceutical company primarily involved in the comprehensive development, production, and global trade of active pharmaceutical ingredients (APIs). Their activities span the manufacturing, processing, sale, import, and export of these essential drug components. The company's extensive product range includes APIs designed for a wide spectrum of therapeutic applications, such as anesthetics, antibiotics, antivirals, cardiovascular agents, central nervous system treatments, anti-inflammatory drugs, and treatments for metabolic disorders like type-II diabetes, among numerous other specialized categories. Beyond its core product offerings, Solara also delivers specialized contract research and manufacturing services (CRAMS) for APIs. These services encompass custom development and manufacturing, analytical support, impurity synthesis, and comprehensive regulatory assistance. The company maintains a significant international presence, exporting its products and conducting operations across diverse global regions, including the Asia Pacific, Europe, North America, and South America. Headquartered in Chennai, India, Solara Active Pharma Sciences Limited was established in 2017. Initially known as SSL Pharma Sciences Limited, the company adopted its current name in March of the same year.

Market cap$256.9M
Employees2,156
Solara Active Pharma Sciences Limited competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Divi's Laboratories and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Divi's Laboratoriesand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →